Cancer care has been transformed by comprehensive molecular profiling and targeted therapies – but with improvements in sample analysis technologies, the volume of information and burden of interpretation has exploded. Physicians need guidance from the laboratories to translate molecular results into clear treatment paths. And with the pace of innovation only accelerating, the gap between discovery and actionable insight is widening fast. Laboratories need resources to help them to manage the information and communicate it to physicians in a reliable and efficient manner.

That’s why leading labs are turning to QCI Precision Insights (formerly N-of-One), a professional clinical variant interpretation service for molecular oncology:

• Trusted, reliable information: A dedicated team of PhD scientists and consulting oncologists translates complex biomarkers into clear, actionable guidance, including report-ready content for the physician to review.

• Real-world clinical impact: Interpretation is supported with FDA drug labels, practice guidelines, clinical trials, and peer-reviewed literature.

• Confidence for physicians, better care for patients: Delivers the insights oncologists need to make faster, more informed decisions – so patients get the right therapy at the right time.